Open-Label Placebo Studied in Children With Abdominal Pain, IBS
Open-label placebo may contribute to therapeutic effect in children and adolescents with functional abdominal pain, irritable bowel syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.